Recent News
May 5, 2026 — Management scheduled a fireside chat at the Bank of America 2026 Healthcare Conference for May 12, 2026, highlighting investor outreach and strategic messaging. May 20, 2026 — The company filed its annual report (Form 10-K), which references the January 9, 2026 completion of the Vivasure Medical acquisition and related disclosures.
Technical Analysis
Directional indicators show a strong trend: ADX at 36.18 indicates a pronounced directional move, with DI+ at 38.19 and increasing while DI‑ at 12.10 falls; that combination produces a bullish directional picture that supports the immediate outlook and complements WMDST’s under‑valued valuation thesis by suggesting market momentum will test that valuation gap.
MACD sits at 4.40 and trends higher, with the MACD line above the signal line at 2.89; that bullish crossover signals expanding upward momentum and aligns with the short-term constructive bias in price relative to the WMDST valuation view.
MRO reads 27.95 and trends decreasing; the positive MRO implies the price sits above its technical target and faces mean-reversion pressure, while the declining MRO reduces the immediacy of that pressure compared with prior readings.
RSI stands at 65.24 and trends higher, indicating sustained buying pressure but approaching overbought territory; that momentum supports near-term continuation while raising the probability of a consolidation phase before further advances.
Price structure and averages reinforce bullish posture: close at $79.84 exceeds the 12‑day EMA ($72.08), 26‑day EMA ($67.11), 20‑day average ($70.51) and 200‑day average ($63.29), signaling price above key support bands and leaving moving averages as the primary dynamic support levels relative to the stated valuation.
Bollinger placement shows the close above the upper 1x band ($76.42) but below the upper 2x band ($82.32), which denotes an extended intraday move without a complete volatility breakout; traders should note the price sits above the SuperTrend lower support at $72.73, offering defined technical support tied to the momentum case.
Volume confirms conviction: today’s volume of 1.75M exceeds the 10‑day average of 1.12M and the 200‑day average of 884k, supporting the momentum narrative and increasing the chance that valuation re-rating scenarios could play out in the short run.
Fundamental Analysis
Revenue and growth: total revenue registers at $346,351,000 with revenue growth listed at 2.18%; quarter-over-quarter revenue change shows a decline of 38.82% while the year‑over‑year figure shows -142.31%, reflecting period-to-period timing effects and one-off comparatives. Earnings per share reported at $1.29 exceeded the $1.27 estimate by $0.02, a positive surprise of 1.58% that supports the recent messaging around improving revenue quality.
Margins and profitability: gross margin at 57.23% falls below the industry peer mean of 63.54% and the industry peer median of 63.29%, while operating margin at 15.11% sits below the industry peer mean of 20.48%. EBIT margin registers negative at -6.65%, materially below the industry peer mean (20.44%) and median (21.81%), reflecting near‑term expense and non‑operating impacts despite operating profit on the books.
Cash flow and liquidity: operating cash flow reached $70,941,000 and free cash flow totaled $53,280,000, producing a free cash flow yield of 1.88%. Cash and short‑term investments stand at $245,440,000 against net debt of $979,140,000; current ratio at 2.95 and quick ratio at 1.87 indicate ample near‑term liquidity even as leverage remains elevated.
Leverage and coverage: total debt equals $1,224,580,000 with debt-to-assets at 51.11% and debt-to-equity at 153.78%, placing leverage above common peer medians. Interest coverage reads negative at -4.28, reflecting an operating/earnings profile that fails to cover interest on a trailing basis and explaining management’s focus on margin expansion and cash conversion.
Valuation metrics: trailing P/E stands near 47.19 while forward P/E appears at 44.09; price-to-book registers at 3.55 and price-to-sales at 8.17. Enterprise value ratio measures roughly 10.99. WMDST values the stock as under‑valued, a conclusion that draws on the company’s improved revenue quality signals, margin expansion potential, and an EVR that leaves room for fundamental upside if execution on cash flow and margin targets continues.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-05-07 |
| NEXT REPORT DATE: | 2026-08-06 |
| CASH FLOW | Begin Period Cash Flow | $ 363.4 M |
| Operating Cash Flow | $ 70.9 M | |
| Capital Expenditures | $ -17.66 M | |
| Change In Working Capital | $ 4.7 M | |
| Dividends Paid | — | |
| Cash Flow Delta | $ -117.93 M | |
| End Period Cash Flow | $ 245.4 M | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 346.4 M | |
| Forward Revenue | $ -280.38 M | |
| COSTS | ||
| Cost Of Revenue | $ 148.1 M | |
| Depreciation | $ 16.8 M | |
| Depreciation and Amortization | $ 27.3 M | |
| Research and Development | $ 14.4 M | |
| Total Operating Expenses | $ 294.0 M | |
| PROFITABILITY | ||
| Gross Profit | $ 198.2 M | |
| EBITDA | $ 4.3 M | |
| EBIT | $ -23.02 M | |
| Operating Income | $ 52.3 M | |
| Interest Income | — | |
| Interest Expense | $ 5.4 M | |
| Net Interest Income | $ -5.37 M | |
| Income Before Tax | $ -28.40 M | |
| Tax Provision | $ -8.25 M | |
| Tax Rate | 29.057 % | |
| Net Income | $ -20.15 M | |
| Net Income From Continuing Operations | $ -20.15 M | |
| EARNINGS | ||
| EPS Estimate | $ 1.27 | |
| EPS Actual | $ 1.29 | |
| EPS Difference | $ 0.02 | |
| EPS Surprise | 1.575 % | |
| Forward EPS | $ 1.44 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 2.4 B | |
| Intangible Assets | $ 1.1 B | |
| Net Tangible Assets | $ -307.70 M | |
| Total Current Assets | $ 834.9 M | |
| Cash and Short-Term Investments | $ 245.4 M | |
| Cash | $ 245.4 M | |
| Net Receivables | $ 216.9 M | |
| Inventory | $ 306.4 M | |
| Long-Term Investments | $ 141.7 M | |
| LIABILITIES | ||
| Accounts Payable | $ 51.1 M | |
| Short-Term Debt | $ 5.0 M | |
| Total Current Liabilities | $ 282.6 M | |
| Net Debt | $ 979.1 M | |
| Total Debt | $ 1.2 B | |
| Total Liabilities | $ 1.6 B | |
| EQUITY | ||
| Total Equity | $ 796.3 M | |
| Retained Earnings | $ 279.3 M | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 17.14 | |
| Shares Outstanding | 45.253 M | |
| Revenue Per-Share | $ 7.45 | |
| VALUATION | Market Capitalization | $ 2.8 B |
| Enterprise Value | $ 3.8 B | |
| Enterprise Multiple | 886.806 | |
| Enterprise Multiple QoQ | 1884.942 % | |
| Enterprise Multiple YoY | 2095.221 % | |
| Enterprise Multiple IPRWA | HAE: 886.806 high: 167.868 mean: 82.388 median: 80.811 low: -193.913 |
|
| EV/R | 10.994 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 3.009 | |
| Asset To Liability | 1.498 | |
| Debt To Capital | 0.606 | |
| Debt To Assets | 0.511 | |
| Debt To Assets QoQ | 3.952 % | |
| Debt To Assets YoY | 2.279 % | |
| Debt To Assets IPRWA | high: 0.725 HAE: 0.511 mean: 0.268 median: 0.249 low: 0.002 |
|
| Debt To Equity | 1.538 | |
| Debt To Equity QoQ | 14.443 % | |
| Debt To Equity YoY | 3.061 % | |
| Debt To Equity IPRWA | high: 4.524 HAE: 1.538 mean: 0.539 median: 0.426 low: -0.465 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 3.552 | |
| Price To Book QoQ | -4.012 % | |
| Price To Book YoY | -6.037 % | |
| Price To Book IPRWA | high: 20.943 mean: 5.629 median: 4.227 HAE: 3.552 low: -12.173 |
|
| Price To Earnings (P/E) | 47.188 | |
| Price To Earnings QoQ | -14.181 % | |
| Price To Earnings YoY | -9.086 % | |
| Price To Earnings IPRWA | high: 194.313 mean: 120.583 median: 98.047 HAE: 47.188 low: -198.766 |
|
| PE/G Ratio | 1.318 | |
| Price To Sales (P/S) | 8.167 | |
| Price To Sales QoQ | -17.925 % | |
| Price To Sales YoY | -12.989 % | |
| Price To Sales IPRWA | high: 62.134 mean: 29.586 median: 21.968 HAE: 8.167 low: 0.285 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 44.088 | |
| Forward PE/G | 1.232 | |
| Forward P/S | -9.825 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -61.589 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.142 | |
| Asset Turnover Ratio QoQ | 3.143 % | |
| Asset Turnover Ratio YoY | 6.812 % | |
| Asset Turnover Ratio IPRWA | high: 0.411 HAE: 0.142 median: 0.128 mean: 0.122 low: 0.002 |
|
| Receivables Turnover | 1.679 | |
| Receivables Turnover Ratio QoQ | -0.246 % | |
| Receivables Turnover Ratio YoY | 5.284 % | |
| Receivables Turnover Ratio IPRWA | high: 3.141 mean: 1.938 HAE: 1.679 median: 1.582 low: 0.361 |
|
| Inventory Turnover | 0.472 | |
| Inventory Turnover Ratio QoQ | 13.619 % | |
| Inventory Turnover Ratio YoY | 24.38 % | |
| Inventory Turnover Ratio IPRWA | high: 2.164 mean: 0.607 median: 0.509 HAE: 0.472 low: 0.137 |
|
| Days Sales Outstanding (DSO) | 54.347 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 230.661 | |
| Cash Conversion Cycle Days QoQ | -4.87 % | |
| Cash Conversion Cycle Days YoY | -0.704 % | |
| Cash Conversion Cycle Days IPRWA | high: 587.726 HAE: 230.661 median: 180.7 mean: 160.138 low: -133.614 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 0.627 | |
| CapEx To Revenue | -0.051 | |
| CapEx To Depreciation | -1.05 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 2.0 B | |
| Net Invested Capital | $ 2.0 B | |
| Invested Capital | $ 2.0 B | |
| Net Tangible Assets | $ -307.70 M | |
| Net Working Capital | $ 552.3 M | |
| LIQUIDITY | ||
| Cash Ratio | 0.869 | |
| Current Ratio | 2.954 | |
| Current Ratio QoQ | 69.013 % | |
| Current Ratio YoY | 82.669 % | |
| Current Ratio IPRWA | high: 14.36 HAE: 2.954 mean: 2.728 median: 2.112 low: 0.038 |
|
| Quick Ratio | 1.87 | |
| Quick Ratio QoQ | 62.195 % | |
| Quick Ratio YoY | 89.734 % | |
| Quick Ratio IPRWA | high: 12.588 mean: 2.016 HAE: 1.87 median: 1.518 low: 0.37 |
|
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 285.184 | |
| Cost Of Debt | 0.311 % | |
| Interest Coverage Ratio | -4.285 | |
| Interest Coverage Ratio QoQ | -147.177 % | |
| Interest Coverage Ratio YoY | -103.592 % | |
| Interest Coverage Ratio IPRWA | high: 87.935 mean: 18.005 median: 13.911 HAE: -4.285 low: -102.892 |
|
| Operating Cash Flow Ratio | 0.011 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 33.322 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | -3.812 % | |
| Revenue Growth | 2.178 % | |
| Revenue Growth QoQ | -38.82 % | |
| Revenue Growth YoY | -142.308 % | |
| Revenue Growth IPRWA | high: 16.503 % HAE: 2.178 % median: -6.009 % mean: -7.868 % low: -65.483 % |
|
| Earnings Growth | 35.789 % | |
| Earnings Growth QoQ | 1036.159 % | |
| Earnings Growth YoY | 751.713 % | |
| Earnings Growth IPRWA | high: 200.0 % HAE: 35.789 % median: -7.623 % mean: -14.509 % low: -145.833 % |
|
| MARGINS | ||
| Gross Margin | 57.229 % | |
| Gross Margin QoQ | -4.15 % | |
| Gross Margin YoY | -1.995 % | |
| Gross Margin IPRWA | high: 95.029 % mean: 63.543 % median: 63.289 % HAE: 57.229 % low: 7.731 % |
|
| EBIT Margin | -6.648 % | |
| EBIT Margin QoQ | -133.436 % | |
| EBIT Margin YoY | -130.809 % | |
| EBIT Margin IPRWA | high: 63.148 % median: 21.811 % mean: 20.437 % HAE: -6.648 % low: -233.035 % |
|
| Return On Sales (ROS) | 15.112 % | |
| Return On Sales QoQ | -24.793 % | |
| Return On Sales YoY | -29.966 % | |
| Return On Sales IPRWA | high: 63.148 % median: 20.603 % mean: 20.477 % HAE: 15.112 % low: -219.267 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 53.3 M | |
| Free Cash Flow Yield | 1.883 % | |
| Free Cash Flow Yield QoQ | -27.185 % | |
| Free Cash Flow Yield YoY | -42.097 % | |
| Free Cash Flow Yield IPRWA | high: 7.748 % HAE: 1.883 % mean: 0.511 % median: 0.47 % low: -15.26 % |
|
| Free Cash Growth | -38.91 % | |
| Free Cash Growth QoQ | 116.672 % | |
| Free Cash Growth YoY | -120.86 % | |
| Free Cash Growth IPRWA | high: 324.237 % mean: -32.269 % median: -37.858 % HAE: -38.91 % low: -397.308 % |
|
| Free Cash To Net Income | -2.645 | |
| Cash Flow Margin | 0.924 % | |
| Cash Flow To Earnings | -0.159 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | -0.825 % | |
| Return On Assets QoQ | -145.48 % | |
| Return On Assets YoY | -135.438 % | |
| Return On Assets IPRWA | high: 5.251 % mean: 2.057 % median: 1.583 % HAE: -0.825 % low: -28.223 % |
|
| Return On Capital Employed (ROCE) | -1.09 % | |
| Return On Equity (ROE) | -0.025 | |
| Return On Equity QoQ | -151.538 % | |
| Return On Equity YoY | -135.815 % | |
| Return On Equity IPRWA | high: 0.413 median: 0.032 mean: 0.031 HAE: -0.025 low: -0.899 |
|
| DuPont ROE | -2.359 % | |
| Return On Invested Capital (ROIC) | -0.808 % | |
| Return On Invested Capital QoQ | -134.325 % | |
| Return On Invested Capital YoY | -128.272 % | |
| Return On Invested Capital IPRWA | high: 8.753 % mean: 2.458 % median: 2.32 % HAE: -0.808 % low: -14.938 % |
|